US EditionModerna stock pulls back after a sharp rally as investors weigh U.S. vaccine backlash risk
3 Articles
3 Articles
Moderna stock pulls back after a sharp rally as investors weigh U.S. vaccine backlash risk
New York, Jan 24, 2026, 06:23 EST — Market closed Moderna shares dropped on Friday following a volatile week, as investors absorbed the company’s caution about mounting U.S. political and regulatory challenges affecting its vaccine development funding. The pullback is significant as Moderna aims to prove it can outgrow its shrinking COVID franchise while funding a costly pipeline. The CEO’s remarks this week highlighted policy risks alongside cl…
Modern strikes. Ready with massive investments. Company, a COVID era titanium, announced drastic cuts for advanced clinical studies. It prevents the development of new vaccines. Why? Because of an increasingly shocking opposition that comes from surprising, even from U.S. officials. The information was given by Cbsnews, and Dr. Céline [...]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
